New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
05:54 EDTCOVCovidien releases study results demonstrating effectiveness of Stellarex DCB
Covidien’s Stellarex drug-coated angioplasty balloon, or Stellarex DCB, continues to be shown as safe and effective for treatment of peripheral arterial disease, or PAD, according to new 24-month data released today from the company’s ILLUMENATE First-in-Human Study. The Stellarex DCB uses EnduraCoat technology, a durable, uniform balloon coating designed to prevent drug loss during transit and facilitate controlled, efficient drug delivery to the treatment site. The study found the Stellarex DCB to be safe, with durable results to 24 months, including: Primary patency was 82.3% at 24 months. Freedom from clinically-driven target lesion revascularization at 24 months was 87.9%. This is the same rate observed at 12 months; no new events were reported demonstrating a sustained low rate of repeat treatment out to 24 months. No amputations or cardiovascular deaths were reported.
News For COV From The Last 14 Days
Check below for free stories on COV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
15:29 EDTCOVNotable companies reporting before tomorrow's open
Subscribe for More Information
14:35 EDTCOVObama to call for elimination of tax inversion deals, NY Times says
President Obama will call on Congress today to eliminate the tax inversion loophole, according to The New York Times. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott’s (ABT), Medtronic's acquisition of Covidien (COV)and Valeant's (VRX) proposed takeover of Alletgan (AGN)Reference Link
July 23, 2014
06:45 EDTCOVLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
July 22, 2014
07:07 EDTCOVCovidien names Bryan Hanson as group president, effective October 1
Subscribe for More Information
July 21, 2014
08:16 EDTCOVDeutsche Bank analysts hold an analyst/industry conference call
Subscribe for More Information
July 18, 2014
12:51 EDTCOVKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
11:34 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
July 17, 2014
11:23 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTCOVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 21st Century Fox (FOXA) downgraded to Buy from Strong Buy at ISI Group... Charter (CHTR) downgraded to Hold from Buy at Jefferies... Covidien (COV) downgraded to Hold from Buy at Needham... Diageo (DEO) downgraded to Underweight from Neutral at JPMorgan... GNC Holdings (GNC) downgraded to Hold from Buy at Jefferies... International Game (IGT) downgraded to Market Perform from Outperform at BMO Capital... JAVELIN Mortgage (JMI) downgraded to Market Perform from Outperform at JMP Securities... Macquarie Group (MQBKY) downgraded to Underweight from Neutral at JPMorgan... PNC Financial (PNC) downgraded to Neutral from Buy at Compass Point... PetSmart (PETM) downgraded to Sector Perform from Outperform at RBC Capital... Rexam (REXMY) downgraded to Hold from Buy at Deutsche Bank.
06:41 EDTCOVCovidien downgraded to Hold from Buy at Needham
Subscribe for More Information
July 16, 2014
10:36 EDTCOVTreasury calls on Congress to halt inversion deals
Subscribe for More Information
07:59 EDTCOVTreasury Secretary urges Congress to take action on tax inversions
Subscribe for More Information
July 14, 2014
10:00 EDTCOVOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:12 EDTCOVCovidien downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
06:31 EDTCOVCovidien downgraded to Neutral from Overweight at Piper Jaffray

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use